LIVECAST Markets Briefs Calendar Search

Research

AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive

LIVECAST Markets

☀◐Theme

Menu

Home LIVECAST Markets Briefs Calendar Search AI Market Assistant Instrument directory Macro Politics Prediction Markets News Archive Account

Live News REGULATION FLASH L impact Sep 28, 2026, 06:30 AM UTC

UK Def Sec Streeting: Manifesto Was Clear, Committed To The Triple Lock

SquawkNews Newsroom

Use this page

Share or save this market-moving headline as a permanent SquawkNews URL. The live feed continues at /news.

Open live news feed Browse news archive Browse news categories Search related coverage

Related tickers

No ticker tags on this item.

Related stories

Ofcom directs Openreach to withdraw 'Incremental New to Openreach' offer Openreach must give Ofcom and the broader industry advance notice before certain commercial offers are introduced. M impact | REGULATION | Sep 28, 2026, 06:35 AM UTC India Supreme Court says food authority should comply with warning label directives Court asks food regulator why it needs to hold industry consultation again on warning labels. M impact | REGULATION | Sep 28, 2026, 06:11 AM UTC Turkey lifts asset freezes on 46 companies in market probe NTV and other media reported the freezes were lifted after new assessments and notifications from the Capital Markets Board. M impact | REGULATION | Sep 28, 2026, 06:10 AM UTC QIAGEN N.V. (QIA) Wins FDA Clearance, Completing U.S. QIAstat-Dx BSI Portfolio QIAGEN received FDA clearance for its QIAstat-Dx BCID GN Plus AMR Panel, enabling U.S. labs to run both gram-negative and gram-positive/fungal bloodstream infection panels on QIAst L impact | REGULATION | Sep 28, 2026, 05:30 AM UTC QIAGEN Completes U.S. QIAstat-Dx Bloodstream Infection Portfolio With FDA Clearance of New Bacteria Detection Panel QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that U.S. laboratories now have access to the complete QIAstat-Dx bloodstream infection portfolio following L impact | REGULATION | Sep 28, 2026, 05:30 AM UTC Weekly Recap: Pipeline and oral GLP-1 scale-up and CagriSema FDA timeline Novo Nordisk A/S Sponsored ADR Class B (OMXCOP:NOVO_B) is executing a cost—cutting, multi—blockbuster push—10x oral GLP—1 capacity, CagriSema launch and Wegovy expansion—while inve L impact | REGULATION | Sep 28, 2026, 05:01 AM UTC

SQUAWK/NEWS

Live financial news for traders. Read the headline on screen or hear it through LiveCast while you stay on the trade.

LiveCast passes from $15 · Institutional API access.

Start LiveCast

Product

Open LiveCast
Plans & Pricing
Institutional API
How LiveCast Works
Live Markets
Session Briefs
RSS Feed
Calendar
Search
Instrument directory

Research

Macro
Politics
Prediction Markets
AI Market Assistant
News Archive

For Traders

Market Movers
US Stocks
Why News Moves Markets
News for Traders
How to Trade the News
What Is an Audio Squawk?
Policy Calendar

Company

About
Why SquawkNews
Newsroom
Editorial Standards
Corrections
Contact us

Legal

Privacy Policy
Terms of Use

© 2026 SquawkNews SquawkNews publishes market information and context. It does not provide investment advice or trade recommendations.